Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials
IntroductionPsychedelic agents have regained the attention of pharmaceutical companies as promising treatments for depressive episodes. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), an atypical psychedelic, is emerging as a potentially effective, novel rapid-acting antidepressant. In this systematic...
Główni autorzy: | , , |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Frontiers Media S.A.
2024-09-01
|
Seria: | Frontiers in Psychiatry |
Hasła przedmiotowe: | |
Dostęp online: | https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1477996/full |